Vanguard Group’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $7.87M | Buy |
|
|||||
|
2017
Q3 | $7.69M | Buy |
|
|||||
|
2017
Q2 | $6.57M | Buy |
|
|||||
|
2017
Q1 | $5.89M | Buy |
|
|||||
|
2016
Q4 | $2.83M | Buy |
|
|||||
|
2016
Q3 | $5.71M | Buy |
|
|||||
|
2016
Q2 | $3.14M | Sell |
|
|||||
|
2016
Q1 | $4.54M | Buy |
|
|||||
|
2015
Q4 | $7.29M | Buy |
|
|||||
|
2015
Q3 | $8.93M | Buy |
|
|||||
|
2015
Q2 | $11.9M | Buy |
|
|||||
|
2015
Q1 | $4.89M | Buy |
|
|||||
|
2014
Q4 | $4.32M | Buy |
|
|||||
|
2014
Q3 | $4.02M | Buy |
|
|||||
|
2014
Q2 | $6.21M | Buy |
|
|||||
|
2014
Q1 | $5.28M | Buy |
|
|||||
|
2013
Q4 | $2.47M | Sell |
|
|||||
|
2013
Q3 | $3.21M | Buy |
|
|||||
|
2013
Q2 | $2.41M | Buy |
|